Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,208 | -64,257 | -38,707 | -13,700 | -16,428 |
| Depreciation Amortization | 1,023 | 961 | 635 | 655 | 297 |
| Accounts receivable | 459 | 325 | 267 | -411 | 1,197 |
| Accounts payable and accrued liabilities | -3,110 | 7,375 | 1,335 | -325 | 926 |
| Other Working Capital | -45,534 | 4,066 | -5,870 | 43,863 | 6,146 |
| Other Operating Activity | 7,626 | -3,686 | -339 | 1,506 | -1,774 |
| Operating Cash Flow | $-67,744 | $-55,216 | $-42,679 | $31,588 | $-9,636 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -605 | -1,370 | -1,143 | -1,084 | -619 |
| Purchase Of Investment | -53,688 | N/A | -145,701 | N/A | N/A |
| Sale Of Investment | 27,000 | 88,565 | 47,220 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -164 |
| Investing Cash Flow | $-27,293 | $87,195 | $-99,624 | $-1,084 | $-783 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,965 | N/A | N/A | N/A | N/A |
| Debt Repayment | -87 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 92,826 | 918 | 68,597 | 105 | N/A |
| Common Stock Repurchased | N/A | 146 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 58,154 | 9,960 |
| Financing Cash Flow | $97,704 | $1,064 | $68,597 | $58,259 | $9,960 |
| Beginning Cash Position | 60,005 | 26,962 | 100,668 | 11,905 | 11,993 |
| End Cash Position | 62,672 | 60,005 | 26,962 | 100,668 | 11,534 |
| Net Cash Flow | $2,667 | $33,043 | $-73,706 | $88,763 | $-459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,744 | -55,216 | -42,679 | 31,588 | -9,636 |
| Capital Expenditure | -605 | -1,370 | -1,143 | -1,084 | -619 |
| Free Cash Flow | -68,349 | -56,586 | -43,822 | 30,504 | -10,255 |